I

IHH Healthcare Bhd
KLSE:IHH

Watchlist Manager
IHH Healthcare Bhd
KLSE:IHH
Watchlist
Price: 8.73 MYR 0.34% Market Closed
Market Cap: 77.1B MYR

IHH Healthcare Bhd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

IHH Healthcare Bhd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
I
IHH Healthcare Bhd
KLSE:IHH
EPS (Diluted)
0
CAGR 3-Years
12%
CAGR 5-Years
64%
CAGR 10-Years
8%
K
KPJ Healthcare Bhd
KLSE:KPJ
EPS (Diluted)
0
CAGR 3-Years
26%
CAGR 5-Years
32%
CAGR 10-Years
10%
F
Focus Point Holdings Bhd
KLSE:FPHB
EPS (Diluted)
0
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cengild Medical Bhd
KLSE:CENGILD
EPS (Diluted)
0
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

IHH Healthcare Bhd
Glance View

In the vast landscape of global healthcare, IHH Healthcare Berhad stands as a towering presence, weaving a complex tapestry of patient care and medical excellence. Born in 2010 from a union of healthcare assets across Asia and beyond, IHH embarked on its journey to becoming one of the world's largest healthcare networks. Its reach spans more than ten countries, stretching from its strongholds in Malaysia and Singapore to burgeoning markets in Turkey, India, and Greater China. The company operates through renowned brands like Pantai, Parkway, and Acibadem, each serving as a hallmark of quality in their respective regions. By offering a comprehensive array of healthcare services, from primary to specialized care, and running top-tier hospitals and ambulatory facilities, IHH manages to touch millions of lives while ensuring an unyielding commitment to clinical excellence. The financial engine that drives IHH pivots on its robust model of vertically integrated healthcare services. Revenue pours in through a multi-faceted approach, chiefly grounded in patient fees for hospital admissions, surgical procedures, and outpatient services. IHH benefits from a strategic alignment with medical enterprises and insurance firms, ensuring a steady influx of patients while also securing long-term partnerships. The company’s emphasis on premium healthcare services, facilitated by cutting-edge technology and skilled practitioners, allows it to charge a premium price point. Moreover, IHH's investment in state-of-the-art technology and medical training bolsters its reputation as a leader in the field, further solidifying its market position. This strategic blend of geographic diversification and healthcare excellence crafts a resilient model that not only profits but also enhances the quality of life across continents.

IHH Intrinsic Value
7.24 MYR
Overvaluation 17%
Intrinsic Value
Price MYR8.73
I

See Also

What is IHH Healthcare Bhd's EPS (Diluted)?
EPS (Diluted)
0.2 MYR

Based on the financial report for Dec 31, 2025, IHH Healthcare Bhd's EPS (Diluted) amounts to 0.2 MYR.

What is IHH Healthcare Bhd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
8%

Over the last year, the EPS (Diluted) growth was -20%. The average annual EPS (Diluted) growth rates for IHH Healthcare Bhd have been 12% over the past three years , 64% over the past five years , and 8% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett